CD86 and head and neck squamous cell carcinoma: CD28, CD86, CD247, and FASLG have previously been shown to be part of small gene sets that are prognosis-related in HNSCC patients (de Vos et al. 2020; Chi et al. 2022; Wang et al. 2022; Zhu et al. 2022).